Ignazia La Torre

1.0k total citations
30 papers, 335 citations indexed

About

Ignazia La Torre is a scholar working on Oncology, Hematology and Molecular Biology. According to data from OpenAlex, Ignazia La Torre has authored 30 papers receiving a total of 335 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 14 papers in Hematology and 8 papers in Molecular Biology. Recurrent topics in Ignazia La Torre's work include Acute Myeloid Leukemia Research (14 papers), Neutropenia and Cancer Infections (6 papers) and Bone health and treatments (5 papers). Ignazia La Torre is often cited by papers focused on Acute Myeloid Leukemia Research (14 papers), Neutropenia and Cancer Infections (6 papers) and Bone health and treatments (5 papers). Ignazia La Torre collaborates with scholars based in Italy, United States and Australia. Ignazia La Torre's co-authors include Emilio Bajetta, Nicoletta Zilembo, Ettore Seregni, Antonia Martinetti, Emilio Bombardieri, C.L. Beach, Barry Skikne, R. Longarini, Andrew H. Wei and Hartmut Döhner and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Annals of Oncology.

In The Last Decade

Ignazia La Torre

29 papers receiving 329 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ignazia La Torre Italy 11 150 136 86 68 51 30 335
Jessica Boklan United States 12 215 1.4× 118 0.9× 134 1.6× 22 0.3× 41 0.8× 30 467
Y Miura Japan 6 168 1.1× 199 1.5× 134 1.6× 35 0.5× 27 0.5× 10 448
Xuzhang Lu China 14 150 1.0× 119 0.9× 212 2.5× 15 0.2× 23 0.5× 54 477
Su‐Chen Lee Taiwan 13 212 1.4× 97 0.7× 21 0.2× 35 0.5× 80 1.6× 20 378
Zhen Shang China 10 242 1.6× 100 0.7× 135 1.6× 27 0.4× 91 1.8× 35 390
Stephen Chanock United States 8 135 0.9× 76 0.6× 21 0.2× 37 0.5× 58 1.1× 10 266
Bettina Wingelhofer Austria 9 205 1.4× 123 0.9× 74 0.9× 14 0.2× 54 1.1× 12 377
Adrianna Henson United States 10 263 1.8× 94 0.7× 50 0.6× 47 0.7× 33 0.6× 17 446

Countries citing papers authored by Ignazia La Torre

Since Specialization
Citations

This map shows the geographic impact of Ignazia La Torre's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ignazia La Torre with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ignazia La Torre more than expected).

Fields of papers citing papers by Ignazia La Torre

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ignazia La Torre. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ignazia La Torre. The network helps show where Ignazia La Torre may publish in the future.

Co-authorship network of co-authors of Ignazia La Torre

This figure shows the co-authorship network connecting the top 25 collaborators of Ignazia La Torre. A scholar is included among the top collaborators of Ignazia La Torre based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ignazia La Torre. Ignazia La Torre is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Roboz, Gail J., Farhad Ravandi, Andrew H. Wei, et al.. (2022). Oral azacitidine prolongs survival of patients with AML in remission independently of measurable residual disease status. Blood. 139(14). 2145–2155. 37 indexed citations
2.
Garcia‐Manero, Guillermo, Hartmut Döhner, Andrew H. Wei, et al.. (2021). Oral Azacitidine (CC-486) for the Treatment of Myeloid Malignancies. Clinical Lymphoma Myeloma & Leukemia. 22(4). 236–250. 16 indexed citations
3.
4.
Tervonen, Tommi, et al.. (2020). Patient Preferences for Maintenance Treatment of Acute Myeloid Leukemia: Results of a Discrete Choice Experiment. Blood. 136(Supplement 1). 38–39. 2 indexed citations
5.
6.
7.
8.
9.
Döhner, Hartmut, Andrew H. Wei, Pau Montesinos, et al.. (2020). Escalated dosing schedules of CC-486 for patients experiencing first acute myeloid leukemia (AML) relapse: Results from the phase III QUAZAR AML-001 maintenance trial.. Journal of Clinical Oncology. 38(15_suppl). 7513–7513. 2 indexed citations
10.
Dunshee, Diana, Yumin Dai, Alberto Risueño, et al.. (2020). CC-486 Mechanism Imparted By Extended Exposure of Azacitidine Upregulates Myeloid Differentiation Markers and Induces Cell Death in AML Cells. Blood. 136(Supplement 1). 33–34. 1 indexed citations
11.
12.
Amadori, D., Ignazia La Torre, Eduardo Carrasco, et al.. (2011). A randomized phase II study of pemetrexed-carboplatin and gemcitabine-vinorelbine in patients with anthracycline- and taxane-pretreated advanced breast cancer.. Journal of Clinical Oncology. 29(15_suppl). 1051–1051. 2 indexed citations
13.
Celio, Luigi, Cora N. Sternberg, Roberto Labianca, et al.. (2009). Pemetrexed in combination with oxaliplatin as a first-line therapy for advanced gastric cancer: a multi-institutional phase II study. Annals of Oncology. 20(6). 1062–1067. 16 indexed citations
14.
Silvestris, Nicola, Saverio Cinieri, Ignazia La Torre, et al.. (2007). Role of gemcitabine in metastatic breast cancer patients: A short review. The Breast. 17(3). 220–226. 44 indexed citations
15.
Martinetti, Antonia, Emilio Bajetta, Luca Ferrari, et al.. (2004). Osteoprotegerin and osteopontin serum values in postmenopausal advanced breast cancer patients treated with anastrozole. Endocrine Related Cancer. 11(4). 771–779. 29 indexed citations
16.
Zilembo, Nicoletta, Emilio Bajetta, E. Bichisao, et al.. (2004). The estrogen suppression after sequential treatment with formestane in advanced breast cancer patients. Biomedicine & Pharmacotherapy. 58(4). 255–259. 8 indexed citations
17.
Bajetta, Emilio, Antonia Martinetti, Nicoletta Zilembo, et al.. (2002). Biological activity of anastrozole in postmenopausal patients with advanced breast cancer: effects on estrogens and bone metabolism. Annals of Oncology. 13(7). 1059–1066. 37 indexed citations
18.
Ferrari, L., Antonia Martinetti, Nicoletta Zilembo, et al.. (2002). Short-term effects of anastrozole treatment on insulin-like growth factor system in postmenopausal advanced breast cancer patients. The Journal of Steroid Biochemistry and Molecular Biology. 80(4-5). 411–418. 10 indexed citations
19.
Procopio, Giuseppe, Emilio Bajetta, Laura Catena, et al.. (2001). Safety and activity of Capecitabine in elderly patients with advanced breast cancer. European Journal of Cancer. 37. S197–S197. 7 indexed citations
20.
Aragona, Marcello, et al.. (2000). Telomere length maintenance in aging and carcinogenesis.. International Journal of Oncology. 17(5). 981–9. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jessica Boklan Breakdown of academic impact, for papers by Y Miura Breakdown of academic impact, for papers by Xuzhang Lu Breakdown of academic impact, for papers by Su‐Chen Lee Breakdown of academic impact, for papers by Zhen Shang Breakdown of academic impact, for papers by Stephen Chanock Breakdown of academic impact, for papers by Bettina Wingelhofer Breakdown of academic impact, for papers by Adrianna Henson
Rankless by CCL
2026